Clinical trial registry record

Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy.

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Withdrawn. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Withdrawn.
Evidence
Registered phase 2 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 15, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05932979
Last registry update
February 15, 2024
Status
Withdrawn
Phase
Phase 2
Sponsor
Centro Universitario de Tonalá
Enrollment
0
Countries
Mexico
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Withdrawn. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 2
Study design
RANDOMIZED · PARALLEL · TREATMENT · DOUBLE
Evidence population
Human clinical study registration
Participants
0
Population
ALL · 60 Years
Duration
2023-05-02 to 2023-12-30
Intervention
L-arginine; Placebo
Comparator
Placebo
Outcomes measured
Baseline Video Head Impulse Test vHIT — Pre-intervention; Final Video Head Impulse Test vHIT — Final (after 90 days of intervention); Baseline Dizziness Handicap Inventory — Pre-intervention; Final Dizziness Handicap Inventory — Final (after 90 days of intervention); Baseline Time up and go Test — Pre-intervention; Final Time up and go Test — Final (after 90 days of intervention); Adverse events — Final (after 90 days of intervention); Initial Audiometry — Pre-intervention; Final Audiometry — Final (after 90 days of intervention)
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 2A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vestibular ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

vestibular aging
Read the original source →Export JSON